Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-12-142348
Filing Date
2012-03-30
Accepted
2012-03-30 11:36:25
Documents
8
Period of Report
2012-03-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d327946d6k.htm 6-K 18991
2 EXHIBIT 99.1 d327946dex991.htm EX-99.1 13685
3 EXHIBIT 99.2 d327946dex992.htm EX-99.2 31284
4 EXHIBIT 99.3 d327946dex993.htm EX-99.3 95449
5 GRAPHIC g327946g12n49.jpg GRAPHIC 20513
6 GRAPHIC g327946g54r52.jpg GRAPHIC 1991
7 GRAPHIC g327946g65q43.jpg GRAPHIC 8766
8 GRAPHIC g327946img004.jpg GRAPHIC 1599
  Complete submission text file 0001193125-12-142348.txt   206417
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 12726900
SIC: 2834 Pharmaceutical Preparations